The new patent regime is challenging the Indian biopharm industry to transition from generics to novel products.
Rakhi Rashmi
Advertisement
Research Scholar at Jawaharlal Nehru University
Articles by Rakhi Rashmi
Advertisement
Latest Updated Articles
Biopharmaceuticals in India: Evolving from Generics to Innovator DrugsPublished: April 1st 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
